Enzymes maker Novozymes on Tuesday reported fourth quarter working revenue under expectations however mentioned it anticipated gross sales to develop organically by between 2-6% within the subsequent monetary yr. www.nasdaq.com
Enzymes maker Novozymes on Tuesday reported fourth quarter working revenue under expectations however mentioned it anticipated gross sales to develop organically by between 2-6% within the subsequent monetary yr.
www.nasdaq.com